Idéal Investisseur
Français English
CAC 40 :
8 157,82 pts
-0.84%


Last updated : 24/04/2026 - 17h35 (last close)
Last close data
🏠 Home   ➤    Stock news

Eurofins Scientific Shares: 2.19% Decline at Close Despite a Positive Week

Eurofins Scientific shares ended the Tuesday, October 21 session down by 2.19%, closing at 62.50 euros compared to 63.90 euros the previous day. This decline goes against the trend of the Parisian market, as the CAC 40 rose by 0.64% at the same time to reach 8,258.86 points. This daily performance contrasts with the weekly dynamics of the analysis laboratory specialist, which still shows a rise of 1.23% over seven days.


Eurofins Scientific Shares: 2.19% Decline at Close Despite a Positive Week

Limited Capital Turnover and Market Divergence

Trading in Eurofins Scientific shares was marked by limited capital turnover, with only 0.42% of shares changing hands during the session. This low activity accompanies a downward movement that brings the price back to 62.50 euros, erasing some of the gains accumulated since the beginning of the week. Over a three-month horizon, the stock still maintains a gain of 1.86%, while the annual performance stands at 10.78%, thus exceeding the 8.48% rise recorded by the CAC 40 index over the same period. The decline observed this Tuesday is set against a bullish market context, highlighting the divergence between the group's trajectory and that of the Parisian market. The beta coefficient of -0.04 indeed reflects an almost absence of correlation between the variations of Eurofins Scientific and those of the benchmark index. This technical characteristic is verified once again today, as the stock moves independently from the general trend of the French equity markets.

Technical Analysis Highlights

Free · Every morning
Technical market signals, before the opening bell.
Bullish and bearish momentum, analyst changes, stocks to watch — automatically computed from Euronext data.
Before 9 AM every morning Euronext data AI-powered analysis

From a technical analysis standpoint, the day's significant event was the crossing below the 50-day moving average. The closing price at 62.50 euros is now below this threshold, positioned at 63.83 euros, signaling a weakening of the short-term momentum. However, the stock still trades above its 200-day moving average, set at 57.11 euros, thus preserving a favorable underlying trend since the beginning of the year. The approach to the technical support threshold identified at 60.80 euros deserves attention, with the price now approaching less than three percent away. Conversely, the resistance at 64.00 euros remains out of immediate reach after today's decline. The Relative Strength Index shows a value of 62, maintaining a neutral zone that indicates neither overbought nor oversold conditions. The MACD maintains a positive setup with a main line at 0.17 above its signal line at 0.05, while the positive histogram at 0.13 suggests the continuation of an underlying bullish momentum. The price moves within the Bollinger Bands, ranging from 60.66 euros to 63.81 euros, indicating contained volatility established at 5.51 over a month.



Sector Santé · Pharmacie Services médicaux


Assurance vie

Context

Period
  • Period: 2025
Key reported figures
  • Revenue: 7 296 M€
  • Revenue growth: 5,0%
  • EBITDA: 1 561 M€
  • EBITDA margin: 21,4%
  • Net income: 473 M€
  • Free cash flow: 876 M€
  • Net debt: 3 641 M€
  • Dividend per share: 0,72 €
Guidance from the release
  • Nous sommes satisfaits d’avoir atteint nos objectifs 2025 et de démontrer la solidité du portfolio Eurofins.
  • La performance 2025 est soutenue par la croissance organique et l’expansion des marges, avec un flux de trésorerie libre robuste et un endettement maîtrisé.

The information presented in this article is provided for informational purposes only and does not constitute an investment recommendation, an incentive to buy or sell a financial asset, or investment advice. Readers are invited to conduct their own research before making any decision.

Investments in the stock market involve risks, including the risk of capital loss. Past performance of an asset or market is no guarantee of future results. Any investment decision should be made taking into account your personal financial situation, objectives and risk tolerance.

Advertisement
Every morning
Technical market signals,
before the opening bell.
CAC 40 · SBF 120 · Signals · Analysts
🤖
Today's edition — pre-market
CAC 40
7 702
-0,87%
SBF 120
5 827
-0,87%
📈 Bullish signals
+5,2%
+1,8%
+0,9%
📉 Bearish signals
-14%
-5,7%
🔄 Analyst opinions
▲ 35 €
▼ 80 €
Sign up to see everything →
Before 9 AM every morning
Euronext data
AI-powered analysis





BOURSE · Chaque matin
La synthèse bourse,
avant l'ouverture.
Notre moteur analyse chaque nuit le CAC 40 et le SBF 120. Ce qui mérite attention remonte directement dans votre boîte mail. Gratuit.
Avant 9h00 1000+ inscrits 100% gratuit